Wells Fargo & Company Increases National Health Investors (NYSE:NHI) Price Target to $86.00

National Health Investors (NYSE:NHIGet Free Report) had its target price hoisted by analysts at Wells Fargo & Company from $85.00 to $86.00 in a research report issued to clients and investors on Friday,Benzinga reports. The firm presently has an “equal weight” rating on the real estate investment trust’s stock. Wells Fargo & Company‘s target price would indicate a potential upside of 4.50% from the company’s current price.

A number of other analysts also recently issued reports on the company. Cantor Fitzgerald set a $85.00 price target on National Health Investors in a report on Monday, January 5th. Deutsche Bank Aktiengesellschaft lowered National Health Investors from a “buy” rating to a “hold” rating and set a $85.00 target price on the stock. in a research report on Tuesday, January 20th. National Bank Financial set a $85.00 target price on National Health Investors in a research note on Tuesday, January 20th. Truist Financial upped their price target on National Health Investors from $85.00 to $92.00 and gave the company a “buy” rating in a report on Thursday, March 12th. Finally, KeyCorp increased their price target on shares of National Health Investors from $80.00 to $88.00 and gave the company an “overweight” rating in a research note on Thursday, December 4th. One research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $86.83.

Check Out Our Latest Analysis on National Health Investors

National Health Investors Trading Down 0.6%

Shares of NYSE:NHI opened at $82.30 on Friday. National Health Investors has a 52 week low of $66.41 and a 52 week high of $91.38. The company’s 50 day moving average is $84.55 and its two-hundred day moving average is $79.80. The company has a market cap of $3.99 billion, a PE ratio of 27.25, a P/E/G ratio of 4.45 and a beta of 0.65. The company has a current ratio of 6.90, a quick ratio of 6.90 and a debt-to-equity ratio of 0.76.

National Health Investors (NYSE:NHIGet Free Report) last released its quarterly earnings data on Thursday, February 26th. The real estate investment trust reported $1.22 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.23 by ($0.01). The firm had revenue of $105.82 million for the quarter, compared to analysts’ expectations of $95.12 million. National Health Investors had a return on equity of 9.56% and a net margin of 37.81%.National Health Investors’s revenue for the quarter was up 6.8% on a year-over-year basis. During the same period last year, the firm posted $1.24 earnings per share. National Health Investors has set its FY 2026 guidance at 4.940-4.990 EPS. Equities analysts predict that National Health Investors will post 4.41 earnings per share for the current fiscal year.

Institutional Trading of National Health Investors

Large investors have recently made changes to their positions in the company. Woodmont Investment Counsel LLC boosted its holdings in shares of National Health Investors by 23.9% in the third quarter. Woodmont Investment Counsel LLC now owns 96,287 shares of the real estate investment trust’s stock valued at $7,655,000 after acquiring an additional 18,582 shares during the period. Strs Ohio increased its holdings in shares of National Health Investors by 293.6% in the 3rd quarter. Strs Ohio now owns 167,300 shares of the real estate investment trust’s stock valued at $13,300,000 after acquiring an additional 124,800 shares during the period. Tudor Investment Corp ET AL increased its holdings in shares of National Health Investors by 189.8% in the 3rd quarter. Tudor Investment Corp ET AL now owns 116,570 shares of the real estate investment trust’s stock valued at $9,267,000 after acquiring an additional 76,339 shares during the period. Bowen Hanes & Co. Inc. raised its position in National Health Investors by 30.0% in the 3rd quarter. Bowen Hanes & Co. Inc. now owns 260,000 shares of the real estate investment trust’s stock valued at $20,670,000 after purchasing an additional 60,000 shares during the last quarter. Finally, Centersquare Investment Management LLC boosted its stake in National Health Investors by 21.8% during the 3rd quarter. Centersquare Investment Management LLC now owns 986,708 shares of the real estate investment trust’s stock worth $78,443,000 after purchasing an additional 176,410 shares during the period. 62.51% of the stock is owned by institutional investors and hedge funds.

About National Health Investors

(Get Free Report)

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.

Read More

Analyst Recommendations for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.